News | Magnetic Resonance Imaging (MRI) | September 19, 2025

Cerebriu Secures CE-Mark for First OEM-Embedded AI Product with Siemens Healthineers

Cerebriu Secures CE Mark for First OEM-Embedded AI Product with Siemens Healthineers

Aug. 29, 2025 - Cerebriu recently announced it had received the CE mark for its Apollo Smart Protocol as an OEM-embedded solution within Siemens Healthineers MRI consoles.

The CE-mark represents a regulatory breakthrough — the first-ever clearance for embedded clinical AI in MRI systems from a leading global manufacturer. Combined with new funding, it paves the way for global deployment of intelligent MRI.

“Radiology is at a pivotal inflection point, where smart clinical AI will define scanner performance,” said Robert Lauritzen, CEO/co-founder of Cerebriu. “CE-marking of the OEM-embedded Apollo Smart Protocol validates the robustness of our technology and proves that AI can be seamlessly integrated into MRI systems at scale.”

Cerebriu’s Apollo Smart Protocol enables MRI technologists to adapt imaging protocols in real time, while the patient is still in the scanner. The AI makes it possible to tailor sequences based on detected pathologies, resulting in more personalized, efficient, and complete imaging in a single exam.

“We’re excited to work with Cerebriu to further unlock smarter MRI workflows. Their ability to integrate AI seamlessly into clinical practice has the potential to accelerate productivity and open new value for both providers and industry,” said Dr. Florian Meise, VP MR Portfolio, Partners and Digital at Siemens Healthineers.

With CE-marking secured for the OEM-integrated Apollo Smart Protocol and strategic partnerships underway with other MRI vendors, Cerebriu is now scaling its Apollo Suite across Europe, the U.S., Asia and the Middle East. The company is now working toward FDA clearance.


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
Subscribe Now